←
Simon Mitchell675 posts
Simon Mitchell avatar

Simon Mitchell

@SiFTW

Systems biology @bsmsMedSchool | UKRI Future Leaders Fellow | co-director @sussex_cancer | Speciality Chief Editor: Systems Immunology @FrontImmunol

◷ Joined May 2008▧ 98 Photos and videos
Simon Mitchell avatar
Simon Mitchell@SiFTW·Oct 23

Huge thanks to @LeukUK and their supporters for making this possible and supporting our work from the ground up. We wouldn't be here without you! Along with @The_MRC for the award to Prof Andrea Pepper that funded Dr Emma Kennedy, and @UKRI_News for the FLF that supports our lab

Simon Mitchell avatar
Simon Mitchell@SiFTW·Oct 23

Proud to have worked on this project led by Emma Kennedy and @andrea_pepper2. Our systems biology models helped show why leukaemia cells respond differently across patients. Blood @BloodPortfolio ashpublications.org/blood/ar… @BSMSMedSchool @Sussex_Cancer @uniofbrighton @SussexUni

🔬 New research involving our funded researcher Prof. Simon Mitchell @SiFTW is helping reveal why CLL responds differently to treatment between patients, including how leukaemia cells can change their survival strategy when treatment stops working. Read more: ashpublications.org/blood/ar…

Post attachment
Sussex Blood Cancer Research avatar
⟳ Simon Mitchell retweeted
Sussex Blood Cancer Research@Sussex_BCR·Oct 20

Good luck to Dr Aimilia Vareli from the @SiFTW group in @BSMSMedSchool who's moving to Boston Children's Hospital and Harvard Medical School. Follows on from winning 1st prize for best short talk at the annual NFkB meeting in Barcelona for her work targeting in DLBCL! 👏👏👏

Post attachmentPost attachmentPost attachment
Simon Mitchell avatar
Simon Mitchell@SiFTW·Jan 28

We’re excited to announce that we’re looking for a postdoctoral research to join our team! This is an opportunity to lead an exciting project aiming to push the boundaries of personalised medicine through integrating data, simulation and lab experiments. mitchell.science/talk/we-are…

Simon Mitchell avatar
Simon Mitchell@SiFTW·9 Oct 2025

I especially owe this promotion to the incredible and inspiring scientists that I’m fortunate enough to call my team, collaborators, and co-directors of @Sussex_Cancer I’m most excited to use my position to repay some of the incredible support I’ve had by supporting others. 🍻

Simon Mitchell avatar
Simon Mitchell@SiFTW·9 Oct 2025

Reflecting triggers imposter syndrome tbh. But I owe it to a series of advisors/supervisors/mentors who believed in me and my approaches. Particularly, Pedro Mendes, @ahoffmann2716, and @ChrisPepper64, who supported me in so many ways from PhD, to postdoc, and PI respectively.

Rhys Morgan avatar
⟳ Simon Mitchell retweeted
Rhys Morgan@RhysMorganLab·30 Sep 2025

Very grateful to have been awarded our 1st @bloodcancer_uk @BloodCancer_Res research grant over the summer for our work targeting aberrant Wnt/β-catenin signalling in acute myeloid leukaemia (AML). New project begins Oct 1st developing new ways to target oncogenic β-catenin 👊

Simon Mitchell avatar
Simon Mitchell@SiFTW·4 Sep 2025

I’ll forever be grateful to @LeukUK and their supporters for being the first to support our work using simulations to tailor treatments in blood cancer. Our lab @BSMSMedSchool and @Sussex_Cancer exists because of you. It was fun to share some of what I’ve learned with ECRs today.

Leukaemia UK@LeukUK4 Sep 2025

“There’s no way I’d be sitting in front of you now if I didn’t receive the John Goldman Fellowship.” Some established researchers share their experiences and advice for those starting out in the field. 🔬🧡

Post attachment
Leukaemia UK avatar
⟳ Simon Mitchell retweeted
Leukaemia UK@LeukUK·4 Sep 2025

“There’s no way I’d be sitting in front of you now if I didn’t receive the John Goldman Fellowship.” Some established researchers share their experiences and advice for those starting out in the field. 🔬🧡

Post attachment
Leukaemia UK avatar
⟳ Simon Mitchell retweeted
Leukaemia UK@LeukUK·22 Aug 2025

Congrats to our John Goldman Fellow, @SiFTW and team! Their research shows how lymphoma cells evade treatment by switching between “survival” pathways. The team have discovered how to predict and overcome this resistance, which could lead to more tailored treatments. 👏

New paper led by Aimilia Vareli out now. nature.com/articles/s41419-0… The lymphoma microenvironment stops BH3-mimetics from working. In vitro/vivo/silico, we find that inhibition of NFκB makes BH3-mimetics great again. 1/🧵 @Sussex_BCR @Sussex_Cancer @LeukUK @BSMSMedSchool #UKRIFLF